Spelling suggestions: "subject:"aancer 3prevention"" "subject:"aancer b.prevention""
31 |
Thermally Processing Broccoli Sprouts Impacts the Metabolism of Bioactive Isothiocyanates in MiceBricker, Gregory Vincent 20 December 2012 (has links)
No description available.
|
32 |
Implementing subtype-specific pre-clinical models of breast cancer to study pre-treatment aspirin effectsMiller, I.S., Khan, S., Shiels, L.P., Das, S., O'Farrell, A.C., Connor, K., Lafferty, A., Moran, B., Isella, C., Loadman, Paul, Conroy, E., Cohrs, S., Schibli, R., Kerbel, R.S., Gallagher, W.M., Marangoni, E., Bennett, K., O'Connor, D.P., Dwyer, R.M., Byrne, A.T. 30 September 2023 (has links)
Yes / Backgorund
Prior data suggest pre-diagnostic aspirin use impacts breast tumour biology and patient outcome. Here, we employed faithful surgical resection models of HER2+ and triple-negative breast cancer (TNBC), to study outcome and response mechanisms across breast cancer subtypes.
Method
NOD/SCID mice were implanted with HER2+ MDA-MB-231/LN/2-4/H2N, trastuzumab-resistant HER2+ HCC1954 or a TNBC patient-derived xenograft (PDX). A daily low-dose aspirin regimen commenced until primary tumours reached ~250 mm3 and subsequently resected. MDA-MB-231/LN/2-4/H2N mice were monitored for metastasis utilising imaging. To interrogate the survival benefit of pre-treatment aspirin, 3 weeks post-resection, HCC1954/TNBC animals received standard-of-care (SOC) chemotherapy for 6 weeks. Primary tumour response to aspirin was interrogated using immunohistochemistry.
Results
Aspirin delayed time to metastasis in MDA-MB-231/LN/2-4/H2N xenografts and decreased growth of HER2+/TNBC primary tumours. Lymphangiogenic factors and lymph vessels number were decreased in HER2+ tumours. However, no survival benefit was seen in aspirin pre-treated animals (HCC1954/TNBC) that further received adjuvant SOC, compared with animals treated with SOC alone. In an effort to study mechanisms responsible for the observed reduction in lymphangiogenesis in HER2+ BC we utilised an in vitro co-culture system of HCC1954 tumour cells and mesenchymal stromal cells (MSC). Aspirin abrogated the secretion of VEGF-C in MSCs and also decreased the lymph/angiogenic potential of the MSCs and HCC1954 by tubule formation assay. Furthermore, aspirin decreased the secretion of uPA in HCC1954 cells potentially diminishing its metastatic capability.
Conclusion
Our data employing clinically relevant models demonstrate that aspirin alters breast tumour biology. However, aspirin may not represent a robust chemo-preventative agent in the HER2+ or TNBC setting. / Funding is acknowledged from the Irish Cancer Society Collaborative Cancer Research Centre under BREAST- PREDICT grant CCRC13GAL (www.breas tpred ict.com). I.S.M, E.M and A.T.B, are members of the EurOPDX Consortium, and receive funding from the European Union's Horizon 2020 research and innovation programme, grant agreement no. #731105 (EurOPDX Research Infrastructure, www.europ dx.eu).
|
33 |
二代測序多基因面板在乳腺癌和卵巢癌篩檢的貝葉斯成本效果分析 / Bayesian cost-effectiveness analysis of NGS multi-gene panel testing for breast and ovarian cancer杜春艷 January 2017 (has links)
University of Macau / Institute of Chinese Medical Sciences
|
34 |
Relationships between masculinity beliefs and colorectal cancer screening in male veteransChristy, Shannon M. January 2015 (has links)
Indiana University-Purdue University Indianapolis (IUPUI) / Men’s adherence to masculinity norms has been implicated as a risk factor for
unhealthy behaviors (e.g., drinking to intoxication, having unprotected sex with multiple,
simultaneous partners) and lack of engagement in healthy behaviors (e.g., blood pressure
screening, cholesterol screening, wearing protective clothing while in the sun, receipt of
annual medical and dental exams) (Boman & Walker, 2010; Courtenay, 2000a, 2000b,
2011; Hammond, Matthews, & Corbie-Smith, 2010; Iwamoto, Cheng, Lee, Takamatsu,
& Gordon, 2011; Locke & Mahalik, 2005; Mahalik, Lagan, & Morrison, 2006; Mahalik
et al., 2003; Nicholas, 2000; Pachankis, Westmaas, & Dougherty, 2011; Pleck,
Sonenstein, & Ku, 1993; Wade, 2009). Masculinity has been defined as behaviors,
beliefs, and personality characteristics associated more often with men than women as
well as characteristics and behaviors that society prescribes and reinforces in men
(Thompson, Pleck, & Ferrera, 1992). Rooted in geographical, cultural, and temporal
environments, diverse masculinities have emerged throughout the United States and the
world (Connell, 1995; Courtenay, 2011). Traditional masculinity beliefs and behaviors in
the United States include the sturdy oak (men should be tough, self-reliant, stoic, and
confident), no sissy stuff (men should avoid feminine characteristics and behaviors), the
big wheel (men should strive for success and status), and give ‘em hell (men should
embrace aggressiveness, daring, and violence) (Brannon, 1976).
Numerous qualitative studies have suggested that some men find cancer screening
examinations involving the rectum (i.e., endoscopy for colorectal cancer [CRC] screening
or digital rectal examination [DRE] for prostate cancer screening) an affront to their
masculinity (see Table 1 for quotations from these studies) (Bass et al., 2011; Beeker,
Kraft, Southwell, & Jorgensen, 2000; Getrich et al., 2012; Goldman, Diaz, & Kim, 2009;
Harvey & Alston, 2011; Holt et al., 2009; Jilcott Pitts et al., 2013; Jones, Devers, Kuzel,
& Woolf, 2010; Rivera-Ramos & Buki, 2011; Thompson, Reeder, & Abel, 2011;
Wackerbarth, Peters, & Haist, 2005; Winterich et al., 2009). However, to the author’s
knowledge, no quantitative studies have considered the role of masculinity in CRC
screening adherence. Unfortunately, current CRC screening rates fall below the 70.5%
Healthy People 2020 screening objective (U.S. Department of Health and Human
Services, 2012).Research is needed to better understand relationships between men’s masculinity
norms and CRC screening adherence so that interventions may be developed to reduce
barriers to screening, improve screening rates, and, ultimately, decrease men’s mortality
from CRC. The present study will address this gap in the literature by examining the
masculinity norms and CRC screening adherence of male veterans aged 51-75 years who
are at average CRC risk (Levin et al., 2008). First, the prevalence of CRC, its risk factors
and warning signs as well as CRC screening techniques, screening rates, and
characteristics of individuals who are adherent and non-adherent to CRC screening
guidelines are summarized. Next, the concept of masculinity, theoretical and empirical
support for studying masculinity norms within the context of CRC screening, and
potential relationships between masculinity norms and colorectal cancer screening
behaviors are described. Finally, the study methods, results, and future directions and
limitations of this research are described.
|
35 |
Mechanistic targets of weight loss-induced cancer prevention by dietary calorie restriction and physical activityStandard, Joseph Tabb January 1900 (has links)
Master of Science / Department of Human Nutrition / Weiqun Wang / Weight control through either dietary calorie restriction (DCR) or exercise is associated with cancer prevention in animal models. However, the underlying mechanisms are not fully defined. Bioinformatics approaches using genomics, proteomics, and lipidomics were employed to elucidate the profiling changes of genes, proteins, and phospholipids in response to weight loss by DCR or exercise in a mouse skin cancer model. SENCAR mice were randomly assigned into 4 groups for 10 weeks: ad lib-fed sedentary control, ad lib-fed exercise (AE), exercise but pair-fed isocaloric amount of control (PE), and 20% DCR. Two hours after topical TPA treatment, skin epidermis was analyzed by Affymetrix for gene expression, DIGE for proteomics, and lipidomics for phospholipids. Body weights were significantly reduced in both DCR and PE but not AE mice versus the control. Among 39,000 transcripts, 411, 67, and 110 genes were significantly changed in DCR, PE, and AE, respectively. The expression of genes relevant to PI3K-Akt and Ras-MAPK signaling was effectively reduced by DCR and PE as measured through GenMAPP software. Proteomics analysis identified ~120 proteins, with 22 proteins significantly changed by DCR, including upregulated apolipoprotein A-1, a key antioxidant protein that decreases Ras-MAPK activity. Of the total 338 phospholipids analyzed by lipidomics, 57 decreased by PE including 5 phophatidylinositol species that serve as PI3K substrates. Although there were many impacts that we still need to characterize, it appears that both Ras-MAPK and PI3K-Akt signaling pathways are the key cancer preventive targets that have been consistently demonstrated by three bioinformatics approaches.
|
36 |
Effect of weight control via dietary calorie restriction and treadmill exercise on lipid profile and overall gene and protein expression in mouse skin tissuesJiang, Yu January 1900 (has links)
Doctor of Philosophy / Department of Human Nutrition / Weiqun Wang / Weight control via dietary caloric restriction and/or exercise has been demonstrated for cancer prevention. However, the underlying mechanisms are not clear. Previous studies in our lab showed that IGF-1 and IGF-1-dependent signaling were reduced by weight control. To confirm the requirement of IGF-1 reduction for cancer prevention, we restored IGF-1 in the exercised mice, which partially reversed the reduction of TPA-induced PI3K expression and PI3K-related 38:4 PI substrate. To explore the overall mechanistic impact, we further studied the effect of weight control on the profiles of lipid, gene and protein expression in TPA treated skin tissues. The mice were randomly assigned into 4 groups: ad libitum-fed sedentary control (control), ad libitum-fed exercise (AL+Exe), exercise but pair-fed at the amount of control (PF+Exe), and 20% of dietary calorie restriction (DCR). At the end of 10 weeks, the mice were treated with TPA topically for two hours. The body weights were significantly reduced in DCR and PF+Exe but not AL+Exe mice when compared with the control. Plasma and skin tissue triacylglycerides were significantly decreased in PF+Exe and DCR groups but not AL+Exe. Similar impact was found for the diacylglyceride profile in both plasma and skin tissue accordingly. Using Affymetrix microarray, 784, 223, and 152 probe sets were respectively found significantly changed by DCR, PF+Exe, and AL+Exe. PF+Exe and DCR showed similar impact on signaling pathways-related gene expression as analyzed by GenMAPP. Of the total 86 proteins identified by 2D-DIGE proteomics, 20 proteins were significantly changed by DCR. Overall, our results showed weight control via DCR or pair-fed exercise rather than exercise with ad libitum feeding significantly reduced body weight and body fat, resulting in reduction of IGF-1 and IGF-1-induced signaling such as PI3K and PI-related pathway. The overall impact upon lipid profiling and gene and protein expression by weight loss suggests many other mechanistic targets. Although we could not ambitiously clarify all the changes were related to anticancer mechanisms in the scope of this study, understanding of the relationship between weight control and TPA-induced skin cancer risk as well as IGF-1-dependent signaling pathways may reveal intrinsic mechanisms and provide novel approaches to prevent cancer in the future studies.
|
37 |
Phytoestrogenic extracts of Cyclopia modulate molecular targets involved in the prevention and treatment of breast cancerVisser, Jacobus Albertus Koch 04 1900 (has links)
Thesis (PhD)--Stellenbosch University, 2014. / ENGLISH ABSTRACT: Phytoestrogen containing extracts of Cyclopia, an indigenous South African fynbos plant used to prepare honeybush tea, may serve as a source of new estrogen analogues. It would be of great benefit if these new analogues would not only prevent the development and progression of breast cancer which, globally, is responsible for the highest number of cancer associated deaths among females, but also have a reduced side-effect profile when compared to current treatments and, in addition, also alleviate menopause associated symptoms. In this study three extracts, P104, SM6Met, and cup-of-tea, from two species of Cyclopia, C. genistoides and C. subternata, were evaluated for their potential to modulate molecular targets involved in prevention and treatment of breast cancer. We show that the phytoestrogenic extracts of Cyclopia antagonise estrogen-induced cell proliferation both in vitro as well as in vivo. Furthermore, our study presents various molecular mechanisms whereby the Cyclopia extracts may be eliciting this effect. Importantly, we show, for the first time, that the Cyclopia extracts behave as ERα antagonists and ERβ agonists which, with respect to the known role of the ER subtypes in breast cancer, where the ERα subtype is associated with the stimulation of cell proliferation and the occurrence of breast cancer, while ERβ ameliorates the action of ERα in breast cancer and could act as an inhibitor of breast cancer development, may be beneficial for the prevention or treatment of breast cancer. In addition, we also show that the extracts of Cyclopia behave as selective estrogen receptor degraders by down-regulating ERα protein levels while stabilising ERβ protein levels, which not only provides a possible molecular explanation for the observed ERα antagonism and ERβ agonism, but, in addition, may be beneficial as higher ERα levels are associated with malignant breast cancer tumours, while higher ERβ levels are associated with benign tumours. Furthermore, we show that the Cyclopia extracts affect the nuclear localization and distribution of both ER subtypes in a manner that provides an additional molecular explanation for the observed ERα antagonism and ERβ agonism. Investigation of the molecular processes involved in the promotion and progression of breast cancer, such as the distribution of cells between the phases of the cell cycle, cancer cell invasion, and the regulation of genes governing these processes provides evidence that the Cyclopia extracts are not as proliferative as estrogen. In addition, Cyclopia extracts display anti-inflammatory properties, which may be beneficial as inflammation is an enabling characteristic in cancer development and progression. Furthermore, this study, for the first time, shows that the phytoestrogenic extracts of Cyclopia are absorbed, are not toxic, and display biological ERα antagonist activity in vivo by retarding uterine growth. Thus, we propose that the Cyclopia extracts act as selective estrogen receptor subtype modulators with potential to be developed as a nutraceutical for the treatment or prevention of breast cancer. / AFRIKAANSE OPSOMMING: Fitoëstrogeen-bevattende ekstrakte van Cyclopia, ‘n inheemse Suid Afrikaanse fynbosplant wat gebruik word vir die voorbereiding van heuningbostee, mag as ‘n bron van nuwe estrogeen-analoë dien. Dit sal baie voordelig wees indien hierdie nuwe analoë nie net die ontwikkeling en progressie van borskanker sal voorkom nie, aangesien borskanker wêreldwyd verantwoordelik is vir die grootste getal kankerverwante sterftes onder vroue, maar ook ‘n verminderde newe-effek profiel vertoon in vergelyking met huidige behandelings en ook, boonop, simptome wat met menopouse geassosieer word, sal verlig. In hierdie studie is drie ekstrakte, P104, SM6Met, en cup-of-tea, vanaf twee spesies van Cyclopia, C. genistoides en C. subternata, geëvalueer vir hul potensiaal om die molekulêre teikens betrokke by die voorkoming en behandeling van borskanker te moduleer. Ons wys dat die fitoëstrogeniese ekstrakte van Cyclopia antagoniseer estrogeen-geïnduseerde selproliferasie beide in vitro as ook in vivo. Verder bied ons studie ook verkskeie molekulêre meganismes aan oor hoe die Cyclopia ekstrakte hierdie effek mag ontlok. ‘n Belangrike bevinding is dat ons vir die eerste keer wys dat die Cyclopia ekstrakte hulself as ERα -antagoniste en ERβ-agoniste gedra wat, met betrekking tot die erkende rol van die ER-subtipes in borskanker, waar die ERα-subtipe geassosieer word met die stimulasie van selproliferasie en die gebeurtenis van borskanker, terwyl ERβ die aksie van ERα onderdruk en as ‘n inhibeerder van borskankerontwikkeling kan dien, voordelig mag wees vir die voorkoming of behandeling van borskanker. Ons wys boonop ook dat die ekstrakte van Cyclopia hulself soos selektiewe estrogeen- reseptor-degradeerders gedra deurdat hul ERα-proteïnvlakke verlaag terwyl hul ERβ-proteïnvlakke stabiliseer. Dit verksaf nie net ‘n moontlike molekulêre verduideliking vir die waargeneemde ERα-antagonisme en ERβ-agonisme nie, maar mag ook voordelig wees in borskanker aangesien hoër ERα-vlakke geasosieer word met kwaadaardige borskankertumors en hoër ERβ-vlakke met nie-kwaadaardige tumors. Verder wys ons dat die Cyclopia ekstrakte die lokalisering en verspreiding van beide ER-subtipes in die selkern op so ‘n wyse beïnvloed dat dit ‘n addisionele molekulêre verduideliking bied vir die ERα-antagonisme en ERβ-agonisme wat waargeneem is. Verdere ondersoek van die molekulêre prosesse betrokke by die promosie en progressie van borskanker, soos die verspreiding van selle tussen die fases van die selsiklus, die beweging van kankerselle na omliggende weefsels, en die regulering van gene wat hierdie prosesse beheer, verskaf bewyse dat die Cyclopia-ekstrakte nie so proliferatief is soos estrogeen nie. Die ekstrakte van Cyclopia vertoon boonop ook anti-inflamatoriese eienskappe, wat voordelig mag wees aangesien inflammasie ‘n bydraende eienskap in kankerontwikkeling en -progressie is. Verder wys hierdie studie vir die eerste keer dat die fitoëstrogeniese ekstrakte van Cyclopia geabsorbeer word, nie toksies is nie, en dat hulle biologiese ERα-antagonis aktiwiteit vertoon deurdat hulle uterus-groei vertraag in vivo. Dus stel ons voor dat die Cyclopia-ekstrakte optree soos selektiewe-estrogeen-reseptor-subtipe-moduleerders met die potensiaal om ontwikkel te word as ‘n nutraseutiese middel vir die behandeling of voorkoming van borskanker.
|
38 |
Role of Helicobacter pylori and non-steroidal anti-inflammatory drugs in prevention of gastric cancerWong, Chun-yu, Benjamin., 王振宇. January 2005 (has links)
published_or_final_version / abstract / Medicine / Doctoral / Doctor of Philosophy
|
39 |
Understanding and evaluating population preventive strategies for breast cancer using statistical and decision analytic modelsWong, Oi-ling, Irene., 黃愛玲 January 2009 (has links)
published_or_final_version / Community Medicine / Doctoral / Doctor of Philosophy
|
40 |
Motivators for Colon Cancer Prevention Among Elderly Mexican AmericansGonzález, Judith T. January 1990 (has links)
This final report documents the theoretical development and preliminary empirical testing of a model that predicts the conditions under which Hispanics will seek preventive health care. Research shows that Hispanics delay preventive care, resulting in higher morbidity and mortality rates for serious diseases such as cancer. Since many serious diseases, such as heart disease, diabetes and cancer can be prevented or treated more effectively if detected early, it is crucial to understand the motivating forces behind Hispanics’ preventive health behavior. The Hispanic model, which is an extension of the Health Behavior in Cancer Prevention Model developed by Atwood, et al. (1986), includes as core variables environmental barriers to access and English-language proficiency, as well as social support, health beliefs, self-efficacy (or perceived skill), health locus of control, and health values.
This correlational descriptive study employed snowballing sampling methods and consisted of 199 Hispanics between 49 and 94 years of age. Measures consist of multi-item scales whose content follows that of the Parent Project. The final instruments showed reliability (Alphas between .69 and .95), although the model testing was limited by the exclusion of some constructs that did not demonstrate reliability. The outcome of predisposition to self-care was predicted by utilization barriers to care, Chance Health Locus of Control, and General Health threat, resulting in an R-square of .07. The findings dealing with dietary preferences and preferred dietary modifications also have great implications for interventions aimed at preventing colon cancer among Hispanics. The practical health policy applications of the model are also discussed.
|
Page generated in 0.1037 seconds